We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+8.91%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$1.77B
AUM Growth
+$297M
Cap. Flow
+$195M
Cap. Flow %
11%
Top 10 Hldgs %
25.89%
Holding
186
New
46
Increased
63
Reduced
28
Closed
46

Top Buys

Rank Stock Value
1
CPAY icon
Corpay
CPAY
+$50.4M
2
BMY icon
Bristol-Myers Squibb
BMY
+$40.6M
3
CNC icon
Centene
CNC
+$33.7M
4
CLVT icon
Clarivate
CLVT
+$27.5M
5
BAX icon
Baxter International
BAX
+$23.8M

Top Sells

Rank Stock Value
1
APP icon
Applovin
APP
+$35.3M
2
CRM icon
Salesforce
CRM
+$28.3M
3
FLEX icon
Flex
FLEX
+$21.2M
4
IPGP icon
IPG Photonics
IPGP
+$18.1M
5
LYFT icon
Lyft
LYFT
+$17.6M

Sector Composition

Rank Sector Weight
1 Technology 30.43%
2 Healthcare 14.56%
3 Communication Services 14.3%
4 Consumer Discretionary 11.94%
5 Industrials 8.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VMEO
76
DELISTED
Vimeo
VMEO
$7.06M 0.4%
1,844,385
+49,461
+3% +$194K
PYPL icon
77
PayPal
PYPL
$50.5B
$6.68M 0.38%
87,970
-133,994
-60% -$10.3M
UA icon
78
Under Armour Class C
UA
$2.44B
$6.62M 0.37%
776,220
-204,460
-21% -$1.88M
INGN icon
79
Inogen
INGN
$160M
$6.49M 0.37%
520,352
+140,098
+37% +$2.68M
UPWK icon
80
Upwork
UPWK
$1.21B
$6.42M 0.36%
567,198
-312,119
-35% -$3.72M
MD icon
81
Pediatrix Medical
MD
$2.12B
$6.17M 0.35%
+413,923
New +$6.27M
CUZ icon
82
Cousins Properties
CUZ
$4.83B
$6.16M 0.35%
+288,193
New +$7.01M
MTCH icon
83
Match Group
MTCH
$8.43B
$6.06M 0.34%
+157,830
New +$6.88M
SMAR
84
DELISTED
Smartsheet Inc.
SMAR
$6.03M 0.34%
126,228
-248,094
-66% -$10.8M
SAMG icon
85
Silvercrest Asset Management
SAMG
$77.6M
$6.01M 0.34%
330,583
+9,223
+3% +$167K
PINC
86
DELISTED
Premier
PINC
$5.73M 0.32%
+177,046
New +$5.8M
NWSA icon
87
News Corp Class A
NWSA
$15.4B
$5.65M 0.32%
+327,388
New +$5.98M
T icon
88
CALL
AT&T
T
$165B
$5.52M 0.31%
286,700
– –
IIIN icon
89
Insteel Industries
IIIN
$626M
$5.14M 0.29%
184,878
+8,264
+5% +$240K
EQX icon
90
Equinox Gold
EQX
$13.5B
$5.14M 0.29%
+998,386
New +$4.16M
SEAT icon
91
Vivid Seats
SEAT
$82.6M
$5.09M 0.29%
33,363
+5,620
+20% +$879K
NGD
92
DELISTED
New Gold Inc
NGD
$5.05M 0.29%
+4,593,526
New +$4.68M
UHS icon
93
Universal Health Services
UHS
$10.2B
$4.93M 0.28%
38,823
-98,668
-72% -$13.6M
SD icon
94
SandRidge Energy
SD
$533M
$4.68M 0.26%
324,725
+8,045
+3% +$123K
SON icon
95
Sonoco
SON
$5.72B
$4.55M 0.26%
+74,515
New +$4.42M
WBA
96
DELISTED
Walgreens Boots Alliance
WBA
$4.52M 0.26%
+130,772
New +$4.64M
INFA
97
DELISTED
Informatica
INFA
$4.52M 0.26%
+275,458
New +$4.68M
FORR icon
98
Forrester Research
FORR
$221M
$4.51M 0.25%
+139,299
New +$4.82M
GEN icon
99
Gen Digital
GEN
$17.5B
$4.49M 0.25%
+261,802
New +$5.25M
LASR icon
100
nLIGHT
LASR
$2.94B
$4.27M 0.24%
419,828
-293,190
-41% -$3.38M
2 3
4
5 6

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Invenomic Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Invenomic Capital Management held 186 positions worth $1.77B, up 20% from $1.47B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Invenomic Capital Management deployed $195M of net new capital in Q1 2023, opening 46 new positions and adding to 63 existing holdings. Its largest new stake was Corpay: 248,424 shares worth $52.4M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Applovin, an estimated $35.3M trimmed.

  • Invenomic Capital Management's largest Q1 2023 buy was Corpay: 248,424 shares worth $52.4M.
  • Invenomic Capital Management added most to Centene in Q1 2023, an estimated $33.7M increase.
  • Invenomic Capital Management's biggest Q1 2023 reduction was Applovin, cutting an estimated $35.3M.
  • Invenomic Capital Management fully exited Salesforce in Q1 2023, selling an estimated $28.3M.
  • Invenomic Capital Management's ten largest holdings make up 26% of its $1.77B portfolio in Q1 2023.
  • Invenomic Capital Management opened 46 new positions and closed 46 in Q1 2023.
  • Invenomic Capital Management's portfolio value rose 20% quarter-over-quarter to $1.77B.

Based on Invenomic Capital Management's 13F filing for Q1 2023, filed 15 May 2023.